Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Study participants We identified all adult (aged 20 years) patients with NAFLD and type 2 diabetes who had newly started treatment with non-insulin glucose-lowering drugs (metformin, GLP-1RAs, SGLT2 inhibitors, sulfonylureas, meglitinides, thiazolidinediones, acarbose or dipeptidyl peptidase-4 inhibitors) between 1 January 2013 and 31 December 2021
To help manage this issue, you might want to identify and reduce these foods in your diet
The trial design and estimands include prespecified strategies for the conduct of the trial during the COVID-19 pandemic (2729)
Semaglutide to Tirzepatide: Switching Guide Switching from semaglutide to tirzepatide is one of the most clinically supported medication transitions in GLP-1 weight loss treatment
Sharps container: For safe disposal after you're done
